Hbk Sorce Advisory LLC Eli Lilly & CO Transaction History

Hbk Sorce Advisory LLC

$2.69 Billion
Q2 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 19,171 shares of LLY stock, worth $17.4 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

19,171

Previous 19,527 1.82%

Holding current value

$17.4 Million

Previous $15.2 Million 14.26%

% of portfolio

0.65%

Previous 0.57%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $258,053 - $323,618	-356 Reduced 1.82%	19,171 $17.4 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $479,089 - $640,954	809 Added 4.32%	19,527 $15.2 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $851,858 - $1 Million	-1,622 Reduced 7.97%	18,718 $10.9 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $385,144 - $530,979	-886 Reduced 4.17%	20,340 $10.9 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $4.98 Million - $6.66 Million	-14,210 Reduced 40.1%	21,226 $9.95 Million
Q1 2023 Aug 15, 2023	BUY	$310.63 - $364.82 $48,458 - $56,911	156 Added 0.73%	21,382 $7.34 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.71 Million - $2 Million	-5,494 Reduced 13.42%	35,436 $19.2 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $7.86 Million - $9.16 Million	24,445 Added 148.29%	40,930 $15 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $12,452 - $14,190	42 Added 0.26%	16,485 $5.33 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.39 Million - $1.63 Million	-4,972 Reduced 23.22%	16,443 $5.33 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $293,597 - $364,866	-1,251 Reduced 5.52%	21,415 $6.13 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $241,039 - $299,130	1,072 Added 4.96%	22,666 $6.26 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $44,320 - $54,541	200 Added 0.93%	21,594 $4.99 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $284,005 - $367,358	1,573 Added 7.94%	21,394 $4.91 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $412,771 - $534,352	-2,512 Reduced 11.25%	19,821 $3.7 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $51,792 - $68,534	-397 Reduced 1.75%	22,333 $3.77 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $238,631 - $276,020	-1,632 Reduced 6.7%	22,730 $3.37 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $106,544 - $128,224	781 Added 3.31%	24,362 $4 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $12,024 - $14,882	-101 Reduced 0.43%	23,581 $3.27 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $6,735 - $8,343	63 Added 0.27%	23,682 $3.11 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $423,742 - $460,922	3,968 Added 20.19%	23,619 $2.64 Million
Q2 2019 Aug 15, 2019	BUY	$110.79 - $129.32 $816,633 - $953,217	7,371 Added 60.02%	19,651 $2.18 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $836,907 - $976,883	-7,554 Reduced 38.09%	12,280 $967,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $19,145 - $22,535	172 Added 0.87%	19,834 $2.57 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $50,726 - $56,828	479 Added 2.5%	19,662 $2.28 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $9,187 - $11,482	-107 Reduced 0.55%	19,183 $2.06 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $9,235 - $10,599	-122 Reduced 0.63%	19,290 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $176,694 - $208,575	-2,381 Reduced 10.93%	19,412 $1.5 Million
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $560,469 - $601,167	6,840 Added 45.74%	21,793 $1.84 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.15 Million - $1.28 Million	14,953	14,953 $1.28 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account

Hbk Sorce Advisory LLC Eli Lilly & CO Transaction History